Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 4, 2010, Pages 246-251

  Djurić, Tamara ^a   Živković, Maja ^a   Stanković, Aleksandra ^a   Kolaković, Ana ^a   Jekić, Djole ^b   Selaković, Vesna ^b   Alavantić, Dragan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Atherosclerosis; Carotid plaque; Collagenase; Correlation; MMP 8

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUTROPHIL COLLAGENASE; UREA;

AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN FUNCTION; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; UREA;

EID: 77955650034     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20393     Document Type: Article

References (18)

1. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005;85:1-31.
2. Nagase H, Woessner Jr JF. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
3. Herman MP, Sukhova GK, Libby P, et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: A novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001;104:1899-1904. (Pubitemid 32983231)
4. Hasty KA, Jeffrey JJ, Hibbs MS, Welgus HG. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 1987;262:10048-10052. (Pubitemid 17103059)
5. Zucker S, Hymowitz M, Conner C, et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci 1999;878:212-227.
6. van den Borne SW, Cleutjens JP, Hanemaaijer R, et al. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 2009;18:37-43.
7. Turu MM, Krupinski J, Catena E, et al. Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006;187:161-169. (Pubitemid 43817009)
8. Molloy KJ, Thompson MM, Jones JL, et al. Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 2004;110:337-343.
9. Tuomainen AM, Nyyssönen K, Laukkanen JA, et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 2007;27:2722-2728. (Pubitemid 350158928)
10. Heider P, Pelisek J, Poppert H, Eckstein HH. Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vasc Endovascular Surg 2009. DOI: 10.1177/ 1538574409334826.
11. Jung K. Matrix metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in serum do not reflect the analytes circulating in blood. Arterioscler Thromb Vasc Biol 2008;28:e15-e16.
12. Kato R, Momiyama Y, Ohmori R, Taniguchi H, Nakamura H, Ohsuzu F. Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease. Circ J 2005;69:1035-1040. (Pubitemid 41603087)
13. Momiyama Y, Ohmori R, Tanaka N, et al. High plasma levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis 2009. DOI: 10.1016/j.atherosclerosis.2009.07.037.
14. Belo VA, Souza-Costa DC, Lana CM, et al. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. Clin Biochem 2009;42:984-990.
15. Aquilante CL, Beitelshees AL, Zineh I. Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease. Clin Chim Acta 2007;379:48-52. (Pubitemid 46366967)
16. Wyman RA, Fraizer MC, Keevil JG, et al. Ultrasound-detected carotid plaque as a screening tool for advanced subclinical atherosclerosis. Am Heart J 2005;150:1081-1085.
17. Krupinski J, Turu MM, Font MA, et al. Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. Vasc Health Risk Manag 2007;3:405-412.
18. Zhang R, Zhang YY, Huang XR, et al. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension 2010;55:953-960.